TELA Bio, Inc.
TELA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.4% | 9.1% | 4.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.5% | 69.8% | 67.6% | 63.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -34.6% | -41.7% | -52.5% | -44.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -41.6% | -49.1% | -60.8% | -52.2% |
| EPS Diluted | -0.19 | -0.22 | -0.25 | -0.23 |
| % Growth | 13.6% | 12% | -8.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |